Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is receiving European Commission and French government funds to develop vaccines that prote… https://t.co/Ijt0cLCBd0
    about 8 hours ago
  • New post on Science and Enterprise: EC, France Fund Universal Covid-19, Flu Vaccines https://t.co/qT6cmb5P1S #Science #Business
    about 9 hours ago
  • Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a dis… https://t.co/S4C9V2nW0p
    about 14 hours ago
  • New post on Science and Enterprise: Univ. Lab Discovers, Licenses Citrus Disease Treatment https://t.co/Hz2YkVgnac #Science #Business
    about 14 hours ago
  • The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines… https://t.co/7P1yBG9iO5
    about 1 day ago

Please share Science & Enterprise

Early Venture Investors Aim for Diverse Entrepreneurs

Business ideas graphic

A new venture investment company is funding start-ups at their earliest stages, with a goal of increasing support for entrepreneurs from all backgrounds. . . . → Read More: Early Venture Investors Aim for Diverse Entrepreneurs

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Start-Up Creating a Simpler, Stable Liquid Biopsy

Blood vials

A new company spun off from University of Oxford is developing a stable and sensitive blood test to detect multiple types of cancer in their early stages. . . . → Read More: Start-Up Creating a Simpler, Stable Liquid Biopsy

Depression Therapy Licensed for Online Distribution

Man with depression

A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital mental health company for online use. . . . → Read More: Depression Therapy Licensed for Online Distribution

GSK, Biotech Partner on Crispr Covid-19 Test

Crispr genome edits illustration

A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline. . . . → Read More: GSK, Biotech Partner on Crispr Covid-19 Test

Symptom App, Algorithm Predict Covid-19 Infections

Android phone

Data from millions of smartphone app users in the U.K. and U.S. reporting on Covid-19 symptoms show they could estimate a population’s Covid-19 infections. . . . → Read More: Symptom App, Algorithm Predict Covid-19 Infections

A.I.-Aided Method Predicts Glaucoma Progression

DARC retinal scan

Clinical trial results show a technique visualizing cells in the retina and analyzed with an algorithm accurately predicts the progression of glaucoma. . . . → Read More: A.I.-Aided Method Predicts Glaucoma Progression

Oxford, AstraZeneca Partner on Covid-19 Vaccine

Covid-19 vaccine infographic

AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford. . . . → Read More: Oxford, AstraZeneca Partner on Covid-19 Vaccine

Psychiatric Drug Maker Raises $80M in Venture Funds

Psilocybe aztecorum

A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing. . . . → Read More: Psychiatric Drug Maker Raises $80M in Venture Funds

Trial Testing Mechanical Ventilator Alternatives

lung illustration

A clinical trial in the U.K. is testing early steps to help the breathing of people hospitalized with Covid-19 infections to avoid later use of mechanical ventilators. . . . → Read More: Trial Testing Mechanical Ventilator Alternatives